Medial arterial calcification in diabetes and its relationship to neuropathy

Diabetologia

Volumn 52, Issue 12, 2009, Pages 2478-2488

  Jeffcoate, W J ^a   Rasmussen, L M ^b   Hofbauer, L C ^c   Game, F L ^a  

^a NOTTINGHAM CITY HOSPITAL   (United Kingdom)

^b ODENSE UNIVERSITY HOSPITAL   (Denmark)

^c DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

Author keywords

Cardiovascular disease; Diabetes; Medial artery calcification; Neuropathy; Osteoporosis; Osteoprotegerin; RANKL; Renal disease; Review

Indexed keywords

CALCITONIN GENE RELATED PEPTIDE; ELASTIN; ENDOCANNABINOID; FETUIN A; HIGH DENSITY LIPOPROTEIN; NEUROPEPTIDE; NITRIC OXIDE; OSTEOCALCIN; OSTEOCLAST DIFFERENTIATION FACTOR; OSTEOPONTIN; OSTEOPROTEGERIN; PHOSPHATE;

ADRENERGIC SYSTEM; ANKLE BRACHIAL INDEX; APOPTOSIS; ARTERIOSCLEROSIS; ARTERY CALCIFICATION; ARTERY MEDIA; ARTERY WALL; AUTONOMIC NEUROPATHY; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHRONIC KIDNEY DISEASE; COMORBIDITY; DIABETES MELLITUS; DISEASE ASSOCIATION; HEMODIALYSIS PATIENT; HORMONE ACTION; HUMAN; MONCKEBERG MEDIAL CALCIFIC SCLEROSIS; MORTALITY; NEUROPATHY; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OSSIFICATION; OSTEOPENIA; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SENSORY NEUROPATHY;

ARTERIES; BLOOD VESSELS; BONE MORPHOGENETIC PROTEIN 2; BONE MORPHOGENETIC PROTEIN 4; CALCINOSIS; CALCITONIN GENE-RELATED PEPTIDE; CELL DIFFERENTIATION; DIABETIC NEUROPATHIES; HUMANS; OSTEOGENESIS; OSTEOPONTIN; TIBIAL ARTERIES; TRANSCRIPTION, GENETIC; TUNICA MEDIA;

EID: 70849125231     PISSN: 0012186X     EISSN: 14320428     Source Type: Journal    
DOI: 10.1007/s00125-009-1521-6     Document Type: Review

References (100)

1. JG Mönckeberg 1903 Uber die reine Mediaverkalkung der Exrtremitätenarterien und ihr Verhalten zur Arteriosklerose Virchows Arch (Pathol Anat) 171 141 167 10.1007/BF01926946 (article in German)
2. JE Everhart DJ Pettit WC Knowler FA Rose PH Bennett 1988 Medial artery calcification and its association with mortality and complications of diabetes Diabetologia 31 16 23 3350219
3. S Lehto L Niskanen M Suhonen T Rönnemaa M Laakso 1996 Medial artery calcification: a neglected harbinger of cardiovascular complications in non-insulin dependent diabetes mellitus Arterioscler Thromb Vasc Biol 16 978 983 8696962
4. Virchow R (1863) Cellular pathology as based upon physiological and pathological histology. Dover, New York
5. R Vattikuti DA Towler 2003 Osteogenic regulation of vascular calcification: an early perspective Am J Physiol: Endocrinol Metab 286 E686 E696 10.1152/ajpendo.00552.2003
6. E Neven S Dauwe ME De Broe PC D'Hause V Persy 2007 Endochondral bone formation is involved in media calcification in rats and in men Kidney Int 72 574 581 10.1038/sj.ki.5002353 17538568 (Pubitemid 47312790)
7. P Collin-Osdoby 2004 Regulation of vascular calcification by osteoclast regulatory factors RANKL and osteoprotegerin Circ Res 95 1046 1057 10.1161/01.RES.0000149165.99974.12 15564564 (Pubitemid 39557891)
8. M Abedin Y Tintut LL Demer 2004 Vascular calcification: mechanisms and clinical ramifications Arterioscler Thromb Vasc Biol 24 1161 1170 10.1161/01.ATV.0000133194.94939.42 15155384 (Pubitemid 38880003)
9. CM Giachelli MY Speer X Li RM Rajachar H Yang 2005 Regulation of vascular calcification: roles of phosphate and osteopontin Circ Res 96 717 722 10.1161/01.RES.0000161997.24797.c0 15831823 (Pubitemid 40559510)
10. LC Hofbauer CC Brueck CM Sanahan M Schoppet H Dobnig 2007 Vascular calcification and osteoporosis-from clinical observation towards molecular understanding Osteoporos Int 18 251 259 10.1007/s00198-006-0282-z 17151836 (Pubitemid 46233170)
11. SM Moe NX Chen 2004 Pathophysiology of vascular calcification in chronic kidney disease Circ Res 95 560 567 10.1161/01.RES.0000141775.67189.98 15375022 (Pubitemid 39274370)
12. M Abedin Y Tintut LL Demer 2004 Mesenchymal stem cells and the artery wall Circ Res 95 671 676 10.1161/01.RES.0000143421.27684.12 15459088 (Pubitemid 39331926)
13. K Boström KE Watson S Horn C Wortham IM Hennan LL Demer 1993 Bone morphogenetic protein expression in human atherosclerotic lesions J Clin Invest 91 1800 1809 10.1172/JCI116391 8473518
14. DJ Mantell PE Owens NJ Bundred EB Mawer AE Canfield 2000 1 alpha, 25-dihydroxyvitamin D(3) inhibits angiogenesis in vitro and in vivo Circ Res 87 214 220 10926872
15. JP Kirton NJ Crofts SJ George K Brennan AE Canfield 2007 Wnt/beta-catenin signalling stimulates chondrogenic and inhibits adipogenic differentiation of pericytes: potential relevance to vascular disease Circ Res 101 581 589 10.1161/CIRCRESAHA.107.156372 17673669 (Pubitemid 351325875)
16. JS Shao J Cai DJ Towler 2006 Molecular mechanisms of vascular calcification: lessons learned from the aorta Arterioscler Thromb Vasc Biol 26 1423 1430 10.1161/01.ATV.0000220441.42041.20 16601233 (Pubitemid 44288965)
17. KQ Nguyen P Olesen T Ledet LM Rasmussen 2007 Bone morphogenetic proteins regulate osteoprotegerin and its ligands in human vascular smooth muscle cells Endocr 32 52 58 10.1007/s12020-007-9007-0 (Pubitemid 350242547)
18. KL Tyson JL Reynolds R McNair Q Zhang PL Weissberg CM Shanahan 2003 Osteo/chondrocytic transcription factors and their target genes exhibit distinct patterns of expression in human arterial calcification Arterioscler Thromb Vasc Biol 23 489 494 10.1161/01.ATV.0000059406.92165.31 12615658 (Pubitemid 36337227)
19. M Eijken S Swagemakers M Koedam C Steenbergen P Derkx AG Uitterlinden 2007 The activin A-follistatin system: potent regulator of human extravascular matrix mineralization FASEB J 21 2949 2960 10.1096/fj.07-8080com 17449718 (Pubitemid 47372761)
20. L Bartholin S Guindon S Martel L Corbo R Rimokh 2007 Identification of NF-kappaB responsive elements in follistatin related gene (FLRG) promoter Gene 393 153 162 10.1016/j.gene.2007.02.007 17395406 (Pubitemid 46566482)
21. Y Hayashi K Maeshima F Got I Kojima 2007 Activin A as a critical mediator of capillary formation: interaction with the fibroblast growth factor action Endocr J 54 311 318 10.1507/endocrj.K06-222 17384470 (Pubitemid 46798654)
22. KA Pavelock BM Girard KC Schutz KM Braas V May 2007 Bone morphogenetic protein down-regulation of neuronal pituitary adenylate cyclase-activating polypeptide and reciprocal effects on vasoactive intestinal peptide expression J Neurochem 100 603 616 10.1111/j.1471-4159.2006.04293.x 17181550 (Pubitemid 46095613)
23. HC Anderson 1995 Molecular biology of matrix vesicles Clin Orthop Relat Res 314 266 280 7634645
24. MC Clarke TD Littlewood N Figg JJ Maguire AP Davenport M Goddard 2008 Chronic apoptosis of vascular smooth muscle cells accelerates atherosclerosis and promotes calcification and medial degeneration Circ Res 102 1529 1538 10.1161/CIRCRESAHA.108.175976 18497329
25. TJ Sims LM Rasmussen H Oxlund AJ Bailey 1996 The role of glycation cross-links in diabetic vascular stiffening Diabetologia 39 946 951 10.1007/BF00403914 8858217
26. SE Greenwald 2007 Ageing of the conduit arteries J Pathol 211 157 172 10.1002/path.2101 17200940 (Pubitemid 46195514)
27. A Simionescu DT Simionescu NR Vyavahare 2007 Osteogenic responses in fibroblasts activated by elastin degradation products and transforming growth factor-β1 Am J Pathol 171 116 123 10.2353/ajpath.2007.060930 17591959 (Pubitemid 47339232)
28. GDM Collett AE Canfield 2005 Angiogenesis and pericytes in the initiation of ectopic calcification Circ Res 96 930 938 10.1161/01.RES.0000163634.51301.0d 15890980 (Pubitemid 40712792)
29. Y Wang C Wan L Deng, et al.. 2007 The hypoxia-inducible factor α pathway couples angiogenesis to osteogenesis during skeletal development J Clin Invest 117 1616 1626 10.1172/JCI31581 17549257 (Pubitemid 46871346)
30. X Li Y Hsueh-Ying CM Giachelli 2006 Role of the sodium-dependent cotransporter, Pit-1, in vascular smooth muscle cell calcification Circ Res 98 905 912 10.1161/01.RES.0000216409.20863.e7 16527991 (Pubitemid 43755243)
31. AP Burke FD Kolodgie R Virmani 2007 Fetuin-A, valve calcification, and diabetes: what do we understand? Circulation 115 2464 2467 10.1161/ CIRCULATIONAHA.107.698324 17502586 (Pubitemid 46763217)
32. R Westenfeld W Jahnen-Dechent M Ketteler 2007 Vascular calcification and fetuin-A deficiency in chronic kidney disease Trends Cardiovasc Med 17 124 128 10.1016/j.tcm.2007.02.005 17482094 (Pubitemid 46670022)
33. K Boström D Tsao S Shen Y Wang LL Demer 2001 Matrix GLA protein modulates differentiation induced by bone morphogenetic protein-2 in C3H10T1/2 cells J Biol Chem 276 14044 14052 11278388
34. PA Price JM Caputo MK Williamson 2002 Bone origin of the serum complex of calcium, phosphate, fetuin, and matrix Gla Protein: biochemical evidence for the cancellous bone-remodelling compartment J Bone Miner Res 7 1171 1179 10.1359/jbmr.2002.17.7.1171
35. T Wada MD McKee GCM Steitz 1999 Calcification of vascular smooth muscle cell cultures: inhibition by osteopontin Circ Res 84 166 178 9933248
36. M Takemoto K Yokote M Nishimura, et al.. 2000 Enhanced expression of osteopontin in human diabetic artery and analysis of its functional role in accelerated atherogenesis Arterioscler Thromb Vasc Biol 20 624 628 10712383
37. LC Hofbauer M Schoppet 2001 Osteoprotegerin: a link between osteoporosis and arterial calcification? Lancet 358 257 259 10.1016/S0140-6736(01)05494-0 11498208 (Pubitemid 32738960)
38. A Rogers R Eastell 2005 Circulating osteoprotegerin and receptor activator for nuclear factor kappaB ligand: clinical utility in metabolic bone disease assessment J Clin Endocrinol Metab 90 6323 6331 10.1210/jc.2005-0794 16105967 (Pubitemid 41606564)
39. N Bucay I Safosi CR Dunstan, et al.. 1998 Osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification Genes Dev 12 1260 1268 10.1101/gad.12.9.1260 9573043
40. M Schoppett N Al-Fakhari FE Franke, et al.. 2004 Localization of osteoprotegerin, tumor necrosis factor-related apoptosis-inducing ligand, and receptor activator of nuclear factor-κB ligand in Mönckeberg's sclerosis and atherosclerosis J Clin Endocrinol Metab 89 4104 4112 10.1210/jc.2003-031432 (Pubitemid 39071519)
41. Z Al-Aly 2008 Arterial calcification: a tumor necrosis factor-alpha mediated vascular Wnt-opathy Transl Res 151 233 239 10.1016/j.trsl.2007.12.005 18433704 (Pubitemid 351545863)
42. S Panizo A Cardus M Encinas, et al.. 2009 RANKL increases vascular smooth muscle cell calcification through a RANK-BMP4-dependent pathway Circ Res 104 1041 1048 10.1161/CIRCRESAHA.108.189001 19325147
43. P Olesen T Ledet LM Rasmussen 2005 Arterial osteoprotegerin: increased amounts in diabetes and modifiable synthesis from vascular smooth muscle cells by insulin and TNF-alpha Diabetologia 48 561 568 10.1007/s00125-004-1652-8 15700136 (Pubitemid 40487304)
44. Y Kanno T Into CJ Lowenstein K Matsushita 2008 Nitric oxide regulates vascular calcification by interfering with TGF-signalling Cardiovasc Res 77 221 230 10.1093/cvr/cvm049 18006450 (Pubitemid 351195162)
45. F Parhami B Basseri J Hwang Y Tintut LL Demer 2002 High-density lipoprotein regulates calcification of vascular cells Circ Res 91 570 576 10.1161/01.RES.0000036607.05037.DA 12364384
46. A Csiszar KE Smith A Koller G Kaley JG Edwards Z Ungvari 2005 Regulation of bone morphogenetic protein-2 expression in endothelial cells Circulation 111 2364 2372 10.1161/01.CIR.0000164201.40634.1D 15851600 (Pubitemid 40655331)
47. CH Kim L You CE Yellowley CR Jacobs 2006 Oscillatory fluid flow-induced shear stress decreases osteoclastogenesis through RANKL and OPG signalling Bone 39 1043 1047 10.1016/j.bone.2006.05.017 16860618 (Pubitemid 44528376)
48. A Jorsal L Tarnow A Flyvbjerg HH Parving P Rossing LM Rasmussen 2008 Plasma osteoprotegerin levels predict cardiovascular and all-cause mortality and deterioration of kidney function in type 1 diabetic patients with nephropathy Diabetologia 51 2100 2107 10.1007/s00125-008-1123-8 18719882
49. PL Selby PA Shearing SM Marshall 1995 Hydroxyproline excretion is increased in diabetes mellitus and related to the presence of microalbuminuria Diabet Med 12 240 243 10.1111/j.1464-5491.1995.tb00465.x 7758261
50. ST Knudsen CH Foss PL Poulsen NH Andersen CE Mogensen LM Rasmussen 2006 Increased plasma concentrations of osteoprotegerin in type 2 diabetic patients with microvascular complications Eur J Endocrinol 149 39 42 10.1530/eje.0. 1490039
51. A Psyrogiannis V Kyriazopoulou AG Vagenakis 1999 Medial arterial calcification is frequently found in patients with microalbuminuria Angiology 50 971 975 10.1177/000331979905001202 10609763
52. M Brownlee 2005 The pathobiology of diabetic complications: a unifying mechanism Diabetes 54 1615 1625 10.2337/diabetes.54.6.1615 15919781 (Pubitemid 40770750)
53. CC Wang V Sorribas G Sharma M Levi B Draznin 2007 Insulin attenuates vascular smooth muscle calcification but increases vascular smooth muscle cell phosphate transport Atherosclerosis 195 e65 e75 10.1016/j.atherosclerosis.2007. 02.032 17412344 (Pubitemid 47561961)
54. WS Browner L-Y Lui SR Cummings 2001 Associations of serum osteoprotegerin levels with diabetes, stroke, bone density, fractures and mortality in elderly women J Clin Endocrinol Metab 86 631 637 10.1210/jc.86.2.631 11158021 (Pubitemid 32207471)
55. M Schoppett AM Sattler JR Schaefer M Herzum B Maisch LC Hofbauer 2003 Increased osteoprotegerin serum levels in men with coronary artery disease J Clin Endocrinol Metab 88 1024 1028 10.1210/jc.2002-020775 (Pubitemid 36337751)
56. A Avignon A Sultan A Piot, et al.. 2005 Osteoprotegerin is associated with silent coronary artery disease in high-risk but asymptomatic type 2 diabetic patients Diabetes Care 28 2176 2180 10.2337/diacare.28.9.2176 16123486 (Pubitemid 41242464)
57. LM Rasmussen L Tarnow TK Hansen H-H Parving A Flyvbjerg 2006 Plasma osteoprotegerin levels are associated with glycaemic status, systolic blood pressure, kidney function and cardiovascular morbidity in type 1 diabetic patients Eur J Endocrinol 154 75 81 10.1530/eje.1.02049 16381994 (Pubitemid 43250739)
58. DV Anand A Lahiri E Lim D Hopkins R Corder 2006 The relationship between plasma osteoprotegerin levels and coronary artery calcification in uncomplicated type 2 diabetic subjects J Am Coll Cardiol 47 1850 1857 10.1016/j.jacc.2005.12. 054 16682312
59. SM Kim J Lee OH Ryu, et al.. 2005 Serum osteoprotegerin levels are associated with inflammation and pulse wave velocity Clin Endocrinol (Oxf) 63 594 598 10.1111/j.1365-2265.2005.02390.x (Pubitemid 41626757)
60. P Secchiero F Corallini A Pandolfi, et al.. 2006 An increased osteoprotegerin serum release characterizes the early onset of diabetes mellitus and may contribute to endothelial cell dysfunction Am J Pathol 169 2236 2244 10.2353/ajpath.2006.060398 17148684 (Pubitemid 351181981)
61. ME Edmonds N Morrison JW Laws PJ Watkins 1982 Medial arterial calcification and diabetic neuropathy BMJ 284 928 930 10.1136/bmj.284.6320.928 6802354
62. MJ Young JE Adams GF Anderson AJ Boulton PR Cavanagh 1993 Medial artery calcification in the feet of diabetic patients and matched non-diabetic controls Diabetologia 36 615 621 10.1007/BF00404070 8359578
63. JA Mayfield MT Caps EJ Boyko JH Ahroni DG Smith 2002 Relationship of medial arterial calcinosis to autonomic neuropathy and adverse outcomes in a diabetic veteran population J Diabet Compl 16 165 171 10.1016/S1056-8727(01) 00178-7 (Pubitemid 34224120)
64. S Sinha CS Munichoodappa GP Kozak 1972 Neuro-arthropathy (Charcot joints) in diabetes mellitus (clinical study of 101 cases) Medicine (Baltimore) 51 191 210 10.1097/00005792-197205000-00006
65. WJ Jeffcoate F Game PR Cavanagh 2005 The role of proinflammatory cytokines in the cause of neuropathic osteoarthropathy (acute Charcot foot) in diabetes Lancet 366 2058 2061 10.1016/S0140-6736(05)67029-8 16338454 (Pubitemid 41773381)
66. M Laroche A Delmotte 2005 Increased arterial calcification in Paget's disease of bone Calcif Tissue Int 77 129 133 10.1007/s00223-005-0250-1 16151674 (Pubitemid 41569741)
67. FD Goebel HS Füessel 1983 Mönckeberg's sclerosis after sympathetic denervation in diabetic and non-diabetic subjects Diabetologia 24 347 350 10.1007/BF00251822 6873514
68. AM Maguire ME Craig A Craighead, et al.. 2007 Autonomic nerve testing predicts the development of complications Diabetes Care 30 77 82 10.2337/dc06-0793 17192337 (Pubitemid 46052502)
69. T Forst A Pfützner P Kann R Lobmann H Schäfer J Beyer 1995 Association between diabetic-autonomic-C-fibre-neuropathy and medial wall calcification in the outcome of trophic foot lesions Exp Clin Endocrinol Diabetes 103 94 98 10.1055/s-0029-1211335 7553081
70. D Naot J Cornish 2008 The role of peptides and receptors of the calcitonin family in the regulation of bone metabolism Bone 43 813 818 10.1016/j.bone.2008.07.003 18687416
71. DW Zochodne VM Verge C Cheng H Sun J Johnston 2001 Does diabetes target ganglion neurones ? Progressive sensory neurone involvement in long-term experimental diabetes Brain 124 2319 2334 10.1093/brain/124.11.2319 11673332
72. Y Jiang JG Nyengaard JS Zhang J Jakobsen 2004 Selective loss of calcitonin gene-related peptide-expressing primary sensory neurons of the a-cell phenotype in early and experimental diabetes Diabetes 53 2669 2675 10.2337/diabetes.53.10.2669 15448099 (Pubitemid 39299277)
73. J La Fontaine LB Harkless VL Sylvia D Carnes J Heim-Hall E Jude 2008 Levels of endothelial nitric oxide synthase and calcitonin gene-related peptide in the Charcot foot: a pilot study J Foot Ankle Surg 47 424 429 10.1053/j.jfas.2008.05.009 18725122
74. JJ McDougall G Yeung CA Leonard RC Bray 2000 A role for calcitonin gene-related peptide in rabbit knee joint ligament healing Can J Physiol Pharmacol 78 535 540 10.1139/cjpp-78-7-535 10926159
75. UH Lerner 2006 Deletions of genes encoding calcitonin/alpha-CGRP, amylin and calcitonin receptor have given new and unexpected insights into the function of calcitonin receptors and calcitonin receptor-like receptors in bone J Musculoskelet Neuronal Interact 6 87 95 16675892
76. J Cornish KE Callon U Bava SA Kamona GJ Cooper IR Reid 2001 Effects of calcitonin, amylin, and calcitonin gene-related peptide on osteoclast development Bone 29 162 168 10.1016/S8756-3282(01)00494-X 11502478 (Pubitemid 32737190)
77. L Mancini N Moradi-Bidhendi ML Brandi M Perretti I MacIntyre 2001 Modulation of the effects of osteoprotegerin (OPG) ligand in a human leukemic cell line by OPG and calcitonin Biochem Biophys Res Comm 279 391 397 10.1006/bbrc.2000.3953
78. I Villa E Mrak A Rubinacci F Ravasi F Guidobono 2006 CGRP inhibits osteoprotegerin production in human osteoblast-like cells via cAMP/PKA-dependent pathway Am J Physiol Cell Physiol 291 C529 C537 10.1152/ajpcell.00354.2005 16611736 (Pubitemid 44343636)
79. M Yamaguchi T Kojima M Kanekawa N Alhara A Nogimura K Kasai 2004 Neuropeptides stimulate production of interleukin-6, and tumor necrosis factor-alpha in human dental pulp cells Inflamm Res 53 199 204 10.1007/s00011-003-1243-z 15105969 (Pubitemid 38626449)
80. CD Martin JM Jimenez-Andrade JR Ghilardi PW Mantyh 2007 Organization of a unique net-like meshwork of CGRP+ sensory fibers in the mouse periosteum: implications for the generation and maintenance of bone fracture pain Neurosci Lett 427 148 152 10.1016/j.neulet.2007.08.055 17950532 (Pubitemid 47633795)
81. E Elefteriou JD Ahn S Takeda, et al.. 2005 Leptin regulation of bone resorption by the sympathetic nervous system Nature 434 514 520 10.1038/nature03398 15724149 (Pubitemid 40477060)
82. K Ishizuka K Hirukawa H Nakamura A Togari 2005 Inhibitory effect of CGRP on osteoclast formation by mouse bone marrow cells treated with isoproterenol Neurosci Lett 379 47 51 10.1016/j.neulet.2004.12.046 15814197 (Pubitemid 40462396)
83. S Armano M Atai S Goto A Togari 2007 Inhibitory effect of NPY on isoprenaline-induced osteoclastogenesis in mouse bone marrow cells Biochim Biophys Acta 1770 966 973
84. Y Do RJ McKallip M Nagarkatti PS Nagarkatti 2004 Activation through cannabinoid receptors 1 and 2 on dendritic cells triggers NF-kappa-B-dependent apoptosis: novel role for endogenous and exogenous cannabinoids in immunoregulation J Immunol 173 2373 2382 15294950
85. K Ono A Tsuchida H Kawai, et al.. 2003 Ankle-brachial blood pressure index predicts all-cause mortality in haemodialysis patients J Am Soc Nephrol 14 1591 1598 10.1097/01.ASN.0000065547.98258.3D 12761260 (Pubitemid 36687061)
86. ND Tussaint PG Kerr 2007 Vascular calcification and arterial stiffness in chronic kidney disease: implications and management Nephrology (Carlton) 12 500 509 10.1111/j.1440-1797.2007.00823.x (Pubitemid 47366641)
87. SS Soedamah-Muthu N Chaturvedi DR Witte LK Stevens M Porta JP Fuller 2008 Relationship between risk factors and mortality in type 1 diabetic patients in Europe Diabetes Care 31 1360 1366 10.2337/dc08-0107 18375412
88. CM Forsblom T Sane PH Groop, et al.. 1998 Risk factors for mortality in Type II (non-insulin dependent) diabetes: evidence of a role for neuropathy and a protective effect of HLA-DR4 Diabetologia 41 1253 1262 10.1007/s001250051062 9833930 (Pubitemid 28488750)
89. DV Coppini PA Bowtell C Weng PJ Young PH Sönksen 2000 Showing neuropathy is related to increased mortality in diabetic patients-a survival analysis using an accelerated failure time model J Clin Epidemiol 53 519 523 10.1016/S0895-4356(99)00170-5 10812325 (Pubitemid 30254349)
90. P Rossing P Hougaard K Borch-Johnsen H-H Parving 1996 Predictors of mortality in insulin-dependent diabetes: 10 year observational follow-up study BMJ 313 779 784 8842069
91. JM Stephenson S Kenny LK Stevens JH Fuller E Lee 1995 Proteinuria and mortality in diabetes: the WHO multinational study of vascular disease in diabetes Diabet Med 12 149 155 10.1111/j.1464-5491.1995.tb00446.x 7743762
92. JC Olson JR Erbey KV Williams, et al.. 2002 Subclinical atherosclerosis and estimated glucose disposal rate as predictors of mortality in type 1 diabetes Ann Epidemiol 12 331 337 10.1016/S1047-2797(01)00269-1 12062921 (Pubitemid 34621493)
93. BK Son K Kozaki K Iijima, et al.. 2006 Statins protect human aortic smooth muscle cells from inorganic phosphate-induced calcification by restoring Gas6-Axi survival pathway Circ Res 98 1024 1031 10.1161/01.RES.0000218859.90970. 8d 16556867 (Pubitemid 43755223)
94. A Trion C Schutte-Bart WH Bax JW Jukema A van der Laarso 2008 Modulation of calcification of vascular smooth muscle cells in culture by calcium antagonists, statins, and their combination Mol Cell Biochem 308 25 33 10.1007/s11010-007-9608-1 17909945 (Pubitemid 351167841)
95. YG Xu SH Zhou YG Li, et al.. 2007 The mechanism underlying vascular smooth muscle cell apoptosis induced by atorvastatin may be mainly associated with down-regulation of survivin expression Cardiovasc Drugs Ther 21 145 153 10.1007/s10557-007-6018-2 17372815 (Pubitemid 46817477)
96. JG Terry JJ Carr EO Kouba, et al.. 2007 Effect of simvastatin (80 mg) on coronary and abdominal aortic calcium (from the coronary artery calcification treatment with zocor [CATZ] study) Am J Cardiol 99 1714 1717 10.1016/j.amjcard.2007.01.060 17560880 (Pubitemid 46874323)
97. DM Maahs JK Snell-Bergeon GL Kinney, et al.. 2007 ACE-I/ARB treatment in type 1 diabetes patients with albuminuria is associated with lower odds of progression of coronary artery calcification J Diab Complicat 21 273 279 10.1016/j.jdiacomp.2006.04.004 (Pubitemid 47348314)
98. CW McIntyre 2007 The functional cardiovascular consequences of vascular calcification Semin Dialysis 20 123 129
99. RJ Hinchliffe B Kirk D Bhattacharjee S Roe W Jeffcoate F Game 2006 The effect of haemodialysis on transcutaneous oxygen tension in patients with diabetes-a pilot study Nephrol Dial Transplant 21 1981 1983 10.1093/ndt/gfl241 16702198 (Pubitemid 43985729)
100. FL Game SY Chipchase R Hubbard RP Burden WJ Jeffcoate 2006 Temporal association between the incidence of foot ulceration and the start of dialysis in diabetes mellitus Nephrol Dial Transplant 21 3207 3210 10.1093/ndt/gfl427 16877485 (Pubitemid 44567095)